Effects of blood products on inflammatory response in endothelial cells in vitro

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Urner, Martin ^a,b   Herrmann, Inge K ^a,b   Buddeberg, Felix ^a   Schuppli, Caroline ^b   Z'graggen, Birgit Roth ^b   Hasler, Melanie ^a   Schanz, Urs ^c   Mehr, Manuela ^a   Spahn, Donat R ^a   Schimmer, Beck Beatrice ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; LIPID; THROMBOCYTE CONCENTRATE; AUTACOID; CD40 LIGAND; CYTOKINE; ENDOTOXIN;

ARTICLE; CELL MIGRATION; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; ERYTHROCYTE CONCENTRATE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LIPID BLOOD LEVEL; MEDIATOR RELEASE; NEUTROPHIL; BLOOD; BLOOD STORAGE; BLOOD TRANSFUSION; CELL MOTION; DRUG EFFECT; PHYSIOLOGY; PLASMA; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE; THROMBOCYTE TRANSFUSION; TIME;

BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD TRANSFUSION; CD40 LIGAND; CELL MOVEMENT; CYTOKINES; ENDOTHELIAL CELLS; ENDOTOXINS; HUMANS; INFLAMMATION MEDIATORS; LIPIDS; NEUTROPHILS; PLASMA; PLATELET TRANSFUSION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS;

EID: 84858380739     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033403     Document Type: Article

References (40)

1. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP, (1999) Transfusion medicine. First of two parts-blood transfusion. N Engl J Med 340: 438-447.
2. Gilliss BM, Looney MR, Gropper MA, (2011) Reducing Noninfectious Risks of Blood Transfusion. Anesthesiology 115: 635-649.
3. Jeschke MG, Chinkes DL, Finnerty CC, Przkora R, Pereira CT, et al. (2007) Blood transfusions are associated with increased risk for development of sepsis in severely burned pediatric patients. Crit Care Med 35: 579-583.
4. Gajic O, Rana R, Winters JL, Yilmaz M, Mendez JL, et al. (2007) Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 176: 886-891.
5. Johnson JL, Moore EE, Kashuk JL, Banerjee A, Cothren CC, et al. (2010) Effect of blood products transfusion on the development of postinjury multiple organ failure. Arch Surg 145: 973-977.
6. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, et al. (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340: 409-417.
7. Dunne J, Malone D, Tracy J, Napolitano L, (2004) Allogenic blood transfusion in the first 24 hours after trauma is associated with increased systemic inflammatory response syndrome (SIRS) and death. Surg Infect 5: 395-404.
8. Gould S, Cimino MJ, Gerber DR, (2007) Packed red blood cell transfusion in the intensive care unit: limitations and consequences. Am J Crit Care 16: 39-49.
9. Shaz BH, Stowell SR, Hillyer CD, (2011) Transfusion-related acute lung injury: from bedside to bench and back. Blood 117: 1463-1471.
10. Silliman CC, Fung LY, Bradley Ball J, Khan SY, (2009) Transfusion-related acute lung injury (TRALI): Current concepts and misconceptions. Blood Rev 23: 245-255.
11. Bux J, Sachs UJ, (2007) The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 136: 788-799.
12. Sachs UJ, (2007) The pathogenesis of transfusion-related acute lung injury and how to avoid this serious adverse reaction of transfusion. Transfus Apher Sci 37: 273-282.
13. Silliman CC, McLaughlin NJ, (2006) Transfusion-related acute lung injury. Blood Rev 20: 139-159.
14. Khan S, Kelher M, Heal J, Blumberg N, Boshkov L, et al. (2006) Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 108: 2455-2462.
15. Silliman CC, Dickey W, Paterson A, Thurman G, Clay K, et al. (1996) Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion 36: 133-139.
16. Silliman CC, Paterson A, Dickey W, Stroneck D, Popovsky M, et al. (1997) The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 37: 719-726.
17. Silliman CC, Ambruso DR, Boshkov LK, (2005) Transfusion-related acute lung injury. Blood 105: 2266-2273.
18. Sheppard D, (2006) Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc Am Thorac Soc 3: 413-417.
19. Bless N, Huber-Lang M, Guo R, Warner R, Schmal H, et al. (2000) Role of CC chemokines (macrophage inflammatory protein-1 beta, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats. J Immunol 164: 2650-2659.
20. Frank J, Wray C, McAuley D, Schwendener R, Matthay MA, (2006) Alveolar macrophages contribute to alveolar barrier dysfunction in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 291: 1191-1198.
21. Urner M, Limbach LK, Herrmann IK, Muller-Edenborn B, Roth-Z'graggen B, et al. (2011) Fluorinated Groups Mediate the Immunomodulatory Effects of Volatile Anesthetics in Acute Cell Injury. Am J Respir Cell Mol Biol.
22. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, et al. (2006) Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 108: 2455-2462.
23. Ludwig A, Petersen F, Zahn S, Götze O, Schröder J, et al. (1997) The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. Blood 90: 4588-4597.
24. Chabrol E, Charonnat R, (1937) Une nouvelle réaction pour l'étude des lipides: L'oleidemie. Presse Med 45: 1713.
25. Benson AB, Moss M, Silliman CC, (2009) Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill. Br J Haematol 147: 431-443.
26. McFaul SJ, Corley JB, Mester CW, Nath J, (2009) Packed blood cells stored in AS-5 become proinflammatory during storage. Transfusion.
27. Sparrow RL, Patton KA, (2004) Supernatant from stored red blood cell primes inflammatory cells: influence of prestorage white cell reduction. Transfusion 44: 722-730.
28. Chin-Yee I, Keeney M, Krueger L, Dietz G, Moses G, (1998) Supernatant from stored red cells activates neutrophils. Transfusion Medicine 8: 49-56.
29. Aye MT, Palmer DS, Giulivi A, Hashemi S, (1995) Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 35: 117-124.
30. Seghatchian J, (2006) Platelet storage lesion: An update on the impact of various leukoreduction processes on the biological response modifiers. Transfus Apher Sci 34: 125-130.
31. Chudziak D, Sireis W, Pfeiffer HU, Henschler R, Seifried E, et al. (2009) Accumulation of soluble inflammatory mediators between blood donation and pre-storage leucocyte depletion. Vox Sanguinis 96: 163-166.
32. Dumont LJ, VandenBroeke T, (2003) Seven-day storage of apheresis platelets: report of an in vitro study. Transfusion 43: 143-150.
33. Schrezenmeier H, Seifried E, (2010) Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred? Vox Sang 99: 1-15.
34. McLaren M, Kennedy G, (2005) Endothelium II: inflammatory response. Surgery (Oxford) 23: 1-6.
35. Vlaar AP, Hofstra JJ, Kulik W, van Lenthe H, Nieuwland R, et al. (2010) Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood 116: 1360-1368.
36. Silliman CC, Moore EE, Kelher MR, Khan SY, Gellar L, et al. (2011) Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion.
37. Strieter RM, Kunkel SL, Showell HJ, Remick DG, Phan SH, et al. (1989) Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science 243: 1467-1469.
38. Remick DG, Ward PA, (2005) Evaluation of endotoxin models for the study of sepsis. Shock 24 (Suppl 1): 7-11.
39. Kumar A, Zanotti S, Bunnell G, Habet K, Anel R, et al. (2005) Interleukin-10 blunts the human inflammatory response to lipopolysaccharide without affecting the cardiovascular response. Crit Care Med 33: 331-340.
40. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, et al. (1989) The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321: 280-287.